Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Abhijit Duggal and Calvin Sheng.
Abhijit Duggal
Connection Strength
0.283
Calvin Sheng
  1. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol. 2020 Oct; 43(10):1055-1063.
    View in: PubMed
    Score: 0.225
  2. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun; 3(6):e410-e418.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.